Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

Blood - 15 Dec 2005

Eliopoulos Nicoletta, Stagg John, Lejeune Laurence, Pommey Sandra, Galipeau Jacques

Abstract excerpt

It has been suggested that marrow stromal cells (MSCs) may be immunoprivileged and can engraft in allogeneic recipients with intact immune systems. We determined if the implantation of murine MSCs engineered to release erythropoietin (Epo) would be feasible in major histocompatibility complex (MHC)-mismatched allogeneic mice without immunosuppression, and we monitored hematocrit (Hct) as a reporter of MSC graft...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Bone Marrow
Share to Bone Marrow Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythropoietin

Share to Graft Rejection

Share to Lymphocyte Culture Test, Mixed

Share to Stromal Cells

Share to Transplantation, Homologous

Source

Identifiers

PMID: 16118325
DOI: 10.1182/blood-2005-03-1004

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.PMID 16118325Read ↗

Mesenchymal Stromal Cells: A New Tool against Graft-versus-Host Disease?Semantic proximity Read ↗

Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in MiceSemantic proximity Read ↗

Cotransplantation of Marrow Stromal Cells May Prevent Lethal Graft-versus-Host Disease in Major Histocompatibility Complex Mismatched Murine Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Immune reconstitution following stem cell transplantationSemantic proximity Read ↗

Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of toleranceSemantic proximity Read ↗

Stem cell engraftment strategies.Semantic proximity Read ↗

Immunogenicity of embryonic stem cell-derived progenitors after transplantationSemantic proximity Read ↗

Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritisSemantic proximity Read ↗

Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.Semantic proximity Read ↗

Undifferentiated Murine Embryonic Stem Cells Cannot Induce Portal Tolerance but May Possess Immune Privilege Secondary to Reduced Major Histocompatibility Complex Antigen ExpressionSemantic proximity Read ↗

Allo-Reactivity of Mesenchymal Stem Cells in Rhesus Macaques Is Dose and Haplotype Dependent and Limits Durable Cell Engraftment In VivoSemantic proximity Read ↗

Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.